Fairvalue-Calculator Fairvalue-Calculator
EN DE

Terragen Holdings (TGH) Fair Value & Analysis

Basic Materials · AU · Market cap A$16.5M

PriceA$0.0200
Fair ValueA$0.0195
Upside-2.3%
Quality95/100
Evidence: Low Range A$0.0178 – A$0.0214

Fair value as of: Jun 26, 2026

Analysis

Terragen Holdings (TGH) currently trades at A$0.0200, while our model-based Fair Value estimate is A$0.0195 — implying the stock looks roughly 2.3% overvalued today. We read business quality at 95/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Terragen Holdings Limited engages in the research, development, and commercialization of biological products for the agriculture sector in Australia and New Zealand. The company offers Mylo and Terragen Probiotic for Ruminants, which are animal feed supplement probiotics for cows and calves; and Great Land Plus, a bio-stimulant for plants. Terragen Holdings Limited was incorporated in 1996 and is based in Coolum Beach, Australia.

Open the full interactive analysis →

Similar stocks

Corteva, Inc (CTVA) -47% Nutrien Ltd (NTR) +29% Qinghai Salt Lake Industry Co (000792) -13% CF Industries Holdings (C1FI34) -67% Yara International ASA (YAR) -84% ICL Group (ICL) -43%

Frequently asked questions

Is Terragen Holdings (TGH) undervalued?
As of Jun 26, 2026, our model estimates a fair value of A$0.0195 versus a price of A$0.0200 — about −2% (overvalued). Model-based estimate, not financial advice.
What is the fair value of TGH?
Our 21-model fair value for Terragen Holdings is A$0.0195 (as of Jun 26, 2026), built from audited fundamentals. The current price is A$0.0200.
What is the quality score of TGH?
Terragen Holdings has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.